Ideas Made to Matter Health Care

How holography could get us to non-invasive surgery

By

Openwater’s Mary Lou Jepsen on how she’ll use holography for cheaper medical imaging and safer surgery.

Jul 13, 2018
Read Article
Ideas Made to Matter Startups

Amazon to acquire PillPack

By

Retail giant reported to pay nearly $1B for the home-delivery pharmacy.

Jun 28, 2018
Read Article
Press Health Care

New study by MIT Sloan researchers provides insights on the challenges of developing drugs for pediatric cancer—and offers a potential solution 

By

Study suggests that a collaborative investment approach between public and private institutions could greatly accelerate innovation.

Jun 2, 2018
Read Article
Ideas Made to Matter Startups

MIT startups Nesterly, Confer Health honored with entrepreneurship awards

By

Celebrating entrepreneurship at MIT a ‘series of religious beliefs.’

Apr 6, 2018
Read Article
Ideas Made to Matter Innovation

Watch: Sanergy’s TEDWomen talk on bringing hygienic sanitation to Africa’s informal settlements

By

Kenya has created hundreds of jobs despite high unemployment.

Apr 5, 2018
Read Article
Ideas Made to Matter Organizational Culture

Use this flowchart to promote a healthy sick leave policy

By

An MIT management expert lays out a clear path to choosing whether it’s better to call in sick or head to the office.

Mar 23, 2018
Read Article
Ideas Made to Matter Health Care

TwoXAR announces Series A in quest to collapse drug discovery timelines

By

Checking in on the company now funded by Softbank, Andreessen Horowitz, and OS Fund.

Mar 21, 2018
Read Article
Ideas Made to Matter Venture Capital

This is the focus of New York-Presbyterian’s venture arm  

By

CFO Phyllis Lantos on the hospital’s tech success and next moves.

Mar 20, 2018
Read Article
Ideas Made to Matter Data

3 lessons industry leaders can teach each other about data and analytics

By

Sports, health care, and education aren’t all that different when it comes to collecting and using data.

Feb 26, 2018
Read Article
Press Health Care

Measuring the risks and rewards of drug development: New research from MIT shows that the success rates of clinical trials are higher than previously thought

By

The study has broad implications for investors, regulators, policymakers, and clinicians

Jan 31, 2018
Read Article
Load More